AOI Biosciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.05M

  • Investors
  • 12

AOI Biosciences General Information

Description

Developer of a genome detection and analysis technology designed to develop diagnostic drugs using enhancers or m-ribonucleic acid. The company's technology helps analyze data on infectious diseases and healthcare with external companies and academia and develop artificial intelligence, enabling pharmaceutical companies to diagnose diseases of ribonucleic acid transcript expression fluctuations from the seed search stage.

Contact Information

Website
www.aoibio.com
Formerly Known As
Revorf
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Saito Bio Innovation Center, 7-7-20 Asagi
  • Saito
  • Ibaraki, Osaka
  • Japan
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Saito Bio Innovation Center, 7-7-20 Asagi
  • Saito
  • Ibaraki, Osaka
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AOI Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 21-Oct-2024 $2.05M Completed Generating Revenue
2. Accelerator/Incubator 10-Mar-2021 Completed Generating Revenue
1. Seed Round 08-Mar-2021 $2.82M $2.82M Completed Generating Revenue
To view AOI Biosciences’s complete valuation and funding history, request access »

AOI Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class A - 1 Preferred
Class A Preferred
To view AOI Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AOI Biosciences Patents

AOI Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7908389-B2 Allosteric path prediction device Active 24-Jun-2022
JP-2026179450-A Allosteric path prediction device, allosteric path prediction method, and program Pending 24-Jun-2022
EP-4546346-A1 Allosteric path prediction device, allosteric path prediction result acquisition method, allosteric path prediction method, and program Pending 24-Jun-2022
WO-2023249117-A1 Allosteric path prediction device, allosteric path prediction result acquisition method, allosteric path prediction method, and program Inactive 24-Jun-2022
US-20260120794-A1 Allosteric path prediction device, allosteric path prediction result acquisition method, and allosteric path prediction method Pending 24-Jun-2022 G16B15/30
To view AOI Biosciences’s complete patent history, request access »

AOI Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AOI Biosciences Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beyondge Venture Capital Minority
Bio Engineering Capital Corporation Minority
Sumitomo Corporation Minority
Toshiba Digital Solutions Corporation Minority
UntroD Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

AOI Biosciences FAQs

  • When was AOI Biosciences founded?

    AOI Biosciences was founded in 2019.

  • Where is AOI Biosciences headquartered?

    AOI Biosciences is headquartered in Ibaraki, Japan.

  • What is the size of AOI Biosciences?

    AOI Biosciences has 22 total employees.

  • What industry is AOI Biosciences in?

    AOI Biosciences’s primary industry is Discovery Tools (Healthcare).

  • Is AOI Biosciences a private or public company?

    AOI Biosciences is a Private company.

  • What is AOI Biosciences’s current revenue?

    The current revenue for AOI Biosciences is .

  • How much funding has AOI Biosciences raised over time?

    AOI Biosciences has raised $4.87M.

  • Who are AOI Biosciences’s investors?

    Beyondge, Bio Engineering Capital, Sumitomo, Toshiba Digital Solutions, and UntroD are 5 of 12 investors who have invested in AOI Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process